The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| WAYSTAR HLDG CORP | COM | 946784105 | 814,801,562 | 24,879,437 | SH | SOLE | 24,879,437 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 95,032,900 | 3,424,609 | SH | SOLE | 3,424,609 | 0 | 0 | ||
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | 117,828,871 | 5,900,294 | SH | SOLE | 5,900,294 | 0 | 0 | ||
| EVOMMUNE INC | COM SHS | 30054Y107 | 84,395,317 | 4,929,633 | SH | SOLE | 4,929,633 | 0 | 0 | ||